Haemorheology and stroke
The view has been growing over a number of years that a correlation exists between haematocrit and the incidence of stroke. This has been the result of studies such as that which took place in Framingham where more than 5000 subjects, free of cerebrovascular disease at entry, were followed for some 16 years'. It was found for both sexes that subjects with haemoglobin concentrations above the mean for their sex had double the risk of a cerebral infarct ofthose whose haemoglobins were below the population mean. A possible mechanism for this relationship is a haemorheological one since it is well known that blood viscosity is particularly sensitive to haematocrit. Furthermore, it has been shown by Thomas et al. 2 that reduction of haematocrit by simple venesection can substantially increase cerebral blood flow, and they suggested that therapeutic venesection might, therefore, be useful in reducing the incidence of stroke. This meeting was concerned mainly with these and other haemorheological associations with stroke.
The meeting was opened by Dr G D 0 Lowe (Royal Infirmary, Glasgow) who first described a number of rheological mechanisms that might be relevant. Blood viscosity has a direct influence on blood flow and peripheral resistance in the macro-circulation, but this is of particular importance distal to atheromatous plaques where substantial loss of driving pressure can be expected. In the microcirculation blood viscosity will also have a role to play, but particularly so where vascular autoregulation is impaired. Here blood cell deformability can also be expected to be of relevance, since vessels of the microcirculation are frequently smaller than the cells themselves.
Dr Lowereminded the audience that previous studies, including some from his own group, had shown that blood taken from patients shortly after an acute stroke had increased blood and plasma viscosities, elevated red cell aggregation and fibrinogen concentration and reduced erythrocyte deformability. However, at least in part, this probably reflects the effects of the acute phase response to the trauma of the stroke. Thus the question still remained: is there a correlation between the rheological data and patient prognosis? His group had, therefore, compared the haemorheologicalprofiles at admissions of 100 patients with acute paretic stroke to mortality or functional recovery (Rankin index) one year later.
It was found that the patients who died had significantly elevated blood viscosity, fibrinogen and leucocyte counts and decreased erythrocyte deformability compared with the survivors. Similar trends were found among survivors who remained dependent compared to those who became independent. However, there were no differences in haematocrit levels between any of the groups. These findings are nevertheless consistent with a role for haemorheological factors in the prevention of cerebral ischaemia.
In the second paper, Dr C S Gray (University of Newcastle upon Tyne) also reported on a study of factors of prognostic value for mortality following stroke. One hundred and twenty-two patients with stroke in a carotid distribution were studied. Haematocrit, haemoglobin, white cell count and urea were measured in blood taken within 72 h of onset of the stroke and their association with mortality at 4 and 12 weeks investigated. As in the previous study, haematocrit (and haemoglobin) showed no prognostic significance. However, increasing age and white cell count were found to be independent factors of prognostic value for mortality at both 4 and 12 weeks following acute stroke.
It has been accepted for some time that erythrocyte deformability has a role to play in determining the rate of flow of blood in the microcirculation. However, only recently has it become realized that leucocytes, in spite of their relatively small number concentration, might also be relevant, this being triggered primarily by the discovery that they are much less deformable than red cells". The next paper by Dr G Ciuffetti (University of Perugia) which reported on a study of the deformability of white cells in acute stroke patients and controls was, therefore, of considerable interest. The cells were separated by density gradient fractionation on Ficol Hypague to give mononuclear and polymorphonuclear fractions, and their filtration characteristics through 5 /Lm filters determined. It was found that both fractions from the patients exhibited reduced deformability when compared with the controls, and this was especially so for the mononuclear cells. These rheologically deleterious changes in the leucocyte together with the association of white blood cell count with post-stroke mortality (reported in the previous two papers) suggest that the white cell may playa role in limiting bloodflowin these conditions.
There then followed two papers reporting on multicentre studies of haemodilution in acute stroke, one from Scandinavia by Dr K Asplund (University of Umea) and the other from Italy by Dr Livia Candelise (University of Milan). The rationale behind both studies derives from data showing that reducing haematocrit dramatically increases cerebral blood flow. Thus it might be expected that haemodilution, by improving blood flow to the region of the stroke, would reduce the severity of the residual neurological damage.
Dr Asplund first discussed the results of a pilot study based on a normovolaemic haemodilution procedure of venesection and fluid replacement with dextran solution, thereby reducing haematocrit to about 37%.This was performed post stroke in the hope of improving prognosis and the results were compared with a group not undergoing haemodilution. It was found to have no effect on survival, but it appeared that the haemodiluted survivors improved more significantly than those who were not haemodiluted. Subsequently, a large 15 centre study was set up. The results of this have, however, proven to be very disappointing since they have shown no increase in Dr Candelise's study was also multicentre and some 1200 patients were investigated. Here haematocrit was reduced to about 35% in 24 h, again normovolaemically by venesection and dextran-solution addition. However, as in the last study, no improvement was discernible from this procedure, and this still obtained when the patient data was analysed separately for those with infarcts and those with haemorrhagic stroke.
In his paper Dr J P G Wade (Charing Cross Hospital, London) described the result of a study of 1377 patients with symptomatic obstructive cerebrovascular disease. These patients were randomized to either medical or surgical (extracranial-intercranial bypass) therapy, and were followed for an average of 56 months. Their outcome was compared with haemoglobin estimates performed at entry. In the medical group there was no difference in the incidence of stroke in those with haemoglobin above 15 gldl compared with those below this haemoglobin level, nor were the strokes more severe. Haemoglobin was also not a prognostic factor in the surgically treated patients. Hence haemoglobin concentration again does not seem to be associated with poor outcome in patients with symptomatic obstructive disease of the carotid or cerebral arteries.
In his paper Dr P N Rogers (Gartnavel General Hospital, Glasgow) studied whole blood viscosity, haematocrit, plasma viscosity and fibrinogen levels in 50 patients with transient ischaemia attacks (TIA), 20 with intermittent claudication and 64 controls. While whole blood viscosity was highest in the claudicants, there was no significant difference between the TIA and control groups. Plasma viscosity and fibrinogen were higher in both TIA and claudicant groups than in the controls. The highest values in TIA patients were seen in those with internal carotid diseases demonstrable by Doppler Scanning. Haematocrit, however, was again not different between the control and TIA groups. Nevertheless, clearly there was a rheological association with each of the diseased groups.
Dr D J Thomas (St Mary's Hospital, London) described the preliminary results in the UK TIA aspirin trial. Nearly 2500 patients had been followed for up to 8 years. They had presented with transient cerebral ischaemic attacks, amaurosis fugax or very minor stroke. One third of the patients were taking placebo, one third were on low dose aspirin (300 mg) and the remaining third were on high dose aspirin (1200 mg), Patients with anaemia and polycythaemia were excluded from the study. Taking the population as a whole, there was no obvious increased risk from stroke, myocardial infarction or vascular death with increasing haematocrit. However, when the placebo group was studied separately it was found that they had significantly greater risk of developing myocardial infarcted stroke or vascular death with increasing haematocrit. Somehow, therefore, aspirin seemed to negate the harmful effects observed in epidemiological studies of haemoglobin and haematocrit. Presumably, aspirin exerts this protection via its known antiplatelet effect. It is possible that the harmful effects of high haematocrit are through the influence of increased red cell numbers enhancing the activation of platelets rather than via the increase in whole blood viscosity.
There was an air of disappointment surrounding this meeting. The findings in the literature that haemoglobin concentration correlates with the incidence of stroke had held out the possibility of its manipulation being a clinically beneficial technique. However, the results reported here would seem to negate this. Nevertheless, there is still strong evidence of rheological association with stroke incidence, possibly relating to interaction with platelets; there are alterations in leucocyte and erythrocyte concentrations and mechanics, and good reasons for expecting these to be of causal significance. Clearly there are complex interactions involved here, and more studies are required to elucidate the situation.
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